PHARMACOKINETICS.

被引：0
|
作者：
Wingard Jr., L.B. [1 ]
机构：
[1] Univ of Pittsburgh, Pittsburgh, PA,, USA, Univ of Pittsburgh, Pittsburgh, PA, USA
来源：
| 1985年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
11
引用
收藏
页码：5 / 15
相关论文
共 50 条
  • [41] Interspecies Pharmacokinetics. 2. Analysis of the Structure of Interspecies Relationships Between Parameters of Drug Pharmacokinetics
    Polekhina, O. V.
    Obraztsov, N. V.
    Petrunin, A.
    Vysotskaya, T. A.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2015, 48 (10) : 635 - 639
  • [42] Renal function and albumin concentration are determinants of mycophenolic acid pharmacokinetics.
    van Hest, RM
    van Gelder, T
    Vulto, AG
    Mathot, RA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P35 - P35
  • [43] Renal function and albumin concentrations are determinants of mycophenolic acid pharmacokinetics.
    vanHest, R
    vanGelder, T
    Vulto, A
    Mathot, R
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 230 - 230
  • [44] Impaired renal function has little or no effect on asenapine pharmacokinetics.
    Peeters, P. A.
    Bock-Brader, H.
    Spaans, E.
    Gibson, G. L.
    De Greef, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S23 - S23
  • [45] MODEL-BASED EVALUATION OF THE EFFECT OF KETOCONAZOLE ON PARITAPREVIR PHARMACOKINETICS.
    Ahmed, M.
    Khatri, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S38 - S38
  • [46] Interspecies Pharmacokinetics. 2. Analysis of the Structure of Interspecies Relationships Between Parameters of Drug Pharmacokinetics
    O. V. Polekhina
    N. V. Obraztsov
    V. A. Petrunin
    T. A. Vysotskaya
    Pharmaceutical Chemistry Journal, 2015, 48 : 635 - 639
  • [47] Interspecies Pharmacokinetics. 1. Allometric Scaling of Pharmacokinetic Parameters (a Review)
    O. V. Polekhina
    N. V. Obraztsov
    V. A. Petrunin
    T. A. Vysotskaya
    Pharmaceutical Chemistry Journal, 2014, 48 : 421 - 429
  • [48] Effect of St. John's Wort on imatinib mesylate pharmacokinetics.
    Frye, RF
    Fitzgerald, SM
    Lagattuta, TF
    Egorin, MJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P96 - P96
  • [49] A phase I trial of CT 2584 mesylate: Clinical effects and pharmacokinetics.
    Garzone, P
    Infortuno, J
    Hesdorffer, M
    Orrico, R
    Shakib, K
    Taub, R
    Keohan, M
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3709S - 3710S
  • [50] Corticosteroid-Binding Globulin (CBG) as an Important Modulator of Cortisol Pharmacokinetics.
    Perogamvros, I.
    Owen, L. J.
    Keevil, B. G.
    Ray, D. W.
    Trainer, P. J.
    ENDOCRINE REVIEWS, 2010, 31 (03)
12345